Clinical Trials
42 trialsE-FACTOR
Centre Leon Berard
HypoRTCx-UG
Uganda Cancer Institute
OvBIOMark
Gustave Roussy, Cancer Campus, Grand Paris
Predictive Assays In Cervix Cancer
University Health Network, Toronto
NUCLEAR
Hospices Civils de Lyon
SPEED
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
Washington University School of Medicine
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
VENUS
University Health Network, Toronto
ESIGON
Assistance Publique - Hôpitaux de Paris
METEOR-CRATR
Washington University School of Medicine
DECIDE
Institut Claudius Regaud
PAIR HPV
Institut Curie
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
UNC Lineberger Comprehensive Cancer Center
GYNO-MIR
Assistance Publique - Hôpitaux de Paris
RAMA
Centre Georges Francois Leclerc
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
University of California, Irvine
PIPADN
Institut de Cancérologie de Lorraine
CTC-COL
University Hospital, Montpellier
EXODIAG
Centre Georges Francois Leclerc
HPV in Blood Samples From Cervical Cancer Patients.
University of Aarhus
PROGENITOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
PICTURE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
MR-O-MICS
Institut du Cancer de Montpellier - Val d'Aurelle
Study of Circulating Tumoral DNA in Ovarian Cancer
Institut Curie
E-CTC
University Hospital, Montpellier
BIO-RAIDs
Institut Curie
ONCOPRO
Hospices Civils de Lyon
Quality of Life Interventions During Cervical Cancer Treatment
University of Iowa
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
GlaxoSmithKline
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects
GlaxoSmithKline
Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)
National University Hospital, Singapore
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
Dana-Farber Cancer Institute
BEDOCA
Sheba Medical Center
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.
GlaxoSmithKline
PIPAC-Secure
Institut du Cancer de Montpellier - Val d'Aurelle
Anti-inflammatory Cells in Peritoneal Cavity
University Hospital, Montpellier
Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
GlaxoSmithKline
Xac03
Assistance Publique Hopitaux De Marseille
miRSa
Centre Francois Baclesse
EXSAL
Centre Francois Baclesse
Assess Cancer in Ovarian Tumors With Biomarkers.
Ciphergen Biosystems